Melanoma differentiation-associated protein 5 (MDA5) is a cytoplasmic pattern recognition receptor that contributes to innate immune detection of viral infection. Activation of MDA5 triggers signaling through MAVS and downstream induction of type I interferons and other antiviral genes. While RIG-I and MDA5 detect different viral infections and RNA features, the precise RNA ligands that activate MDA5 in infected cells have remained incompletely defined.
To investigate the RNAs engaged by MDA5, the authors applied single-nucleotide resolution crosslinking and immunoprecipitation (iCLIP). This approach allowed mapping of MDA5–RNA contacts across the transcriptome during infection. The study compared infections with two viruses that engage MDA5 in different contexts: SARS-CoV-2 and encephalomyocarditis virus (EMCV).
A striking observation was that, upon infection with either SARS-CoV-2 or EMCV, MDA5 bound overwhelmingly to cellular RNAs rather than to viral RNAs. The iCLIP data demonstrated that the majority of MDA5 contacts mapped to host transcripts. This finding shifts emphasis from a sole focus on pathogen-derived PAMPs to the possibility that perturbations of host RNA populations contribute substantially to MDA5 activation during infection.
Many of the mapped MDA5 binding sites were located within intronic regions of host genes. These intronic peaks were frequently found close to Alu repetitive elements and to sequences predicted to form base-paired secondary structures. The association with introns and Alu-proximal, potentially double-stranded structures suggests that MDA5 recognizes RNA features that arise from or are exposed by abnormal processing of pre-mRNAs.
Concomitant with the pattern of MDA5 binding, infected cells displayed elevated cytoplasmic levels of aberrant transcripts and of intron-containing unspliced RNAs. These aberrant RNA species were enriched for MDA5 iCLIP peaks, indicating that the RNAs accumulating during infection are direct targets of MDA5 binding. The data therefore link infection-driven loss of RNA homeostasis—manifest as increased aberrant and unspliced transcripts in the cytoplasm—with MDA5 engagement.
To test whether improving RNA processing affects MDA5 activation, the authors overexpressed the splicing factor SRSF3. Overexpression of SRSF3 reduced levels of aberrant transcription and abrogated MDA5 activation in the experimental context. This functional manipulation supports the interpretation that defects in post-transcriptional RNA processing, and not only the presence of foreign viral RNA, can drive MDA5-dependent innate immune signaling.
Taken together, the observations support a model in which MDA5 surveys RNA processing fidelity and can detect infection by sensing perturbations of post-transcriptional events such as splicing. During viral infection, accumulation of intron-containing and otherwise aberrant cellular RNAs—and their presentation in the cytoplasm—provides ligands that recruit and activate MDA5. Overexpression of a splicing factor diminished these aberrant RNAs and prevented MDA5 activation, providing experimental support for the model.
This framework expands the conceptual repertoire for how nucleic acid sensors discriminate infected from uninfected states: in addition to recognizing pathogen-specific RNA signatures, sensors like MDA5 may respond to loss of host RNA homeostasis. The source article reports the experimental data, mapping results and analyses that underpin these conclusions; specific numerical results and methodological parameters are provided in the original report but are not reproduced in detail here.
If MDA5 activation can result from perturbations of host RNA processing, therapeutic strategies that modulate RNA-processing fidelity or that limit the cytoplasmic accumulation of aberrant transcripts could influence innate immune activation during infection or in diseases characterized by dysregulated RNA metabolism. Conversely, understanding which host RNA species trigger MDA5 may help explain pathological type I interferon responses associated with excessive or chronic activation of nucleic acid sensors. The authors' data motivate further mechanistic and translational studies to define the molecular features of endogenous RNAs that most potently activate MDA5 and to assess how these pathways operate across different infections and cell types.